Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 12(6)2020 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-32471262

RESUMEN

There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality.


Asunto(s)
Diabetes Mellitus Tipo 2/tratamiento farmacológico , Emulsiones Grasas Intravenosas/uso terapéutico , Aceites de Pescado/uso terapéutico , Nutrición Parenteral Total/efectos adversos , Triglicéridos/metabolismo , Anciano , Anciano de 80 o más Años , Glucemia , Ácidos Grasos Omega-3/uso terapéutico , Femenino , Humanos , Hipoglucemiantes , Insulina , Hígado/metabolismo , Masculino , Persona de Mediana Edad , Nutrición Parenteral , Triglicéridos/sangre
2.
Endocrinol Diabetes Nutr (Engl Ed) ; 65(1): 5-16, 2018 Jan.
Artículo en Inglés, Español | MEDLINE | ID: mdl-29233514

RESUMEN

BACKGROUND: Imprecision in terms used in the field of clinical nutrition may lead to misinterpretations among professionals. OBJECTIVE: For this reason, the Spanish Society of Endocrinology and Nutrition (SEEN) promoted this document on the terms and definitions used in clinical artificial nutrition (enteral and parenteral), establishing an agreement between Spanish experts of this specialty. METHODS: Forty-seven specialists in endocrinology and nutrition, members of the Nutrition Area of the SEEN, participated between April and September 2016. After a systematic literature review, 52 concepts were proposed. The coordinators included two additional concepts, and 57were finally selected by the working group: 13 of a general nature, 30 referring to enteral nutrition and 14 to parenteral nutrition. The degree of agreement was subsequently determined using a two-round Delphi process. It was finally ratified by consistency and concordance analysis. RESULTS: Fifty-four of the 57 terms had a very consistent agreement and were concordant. Only three showed no concordance, of whom two were very consistent and one inconsistent. In conclusion, there was consensus in the definition of 54 basic terms in the practice of clinical nutrition.


Asunto(s)
Ciencias de la Nutrición , Apoyo Nutricional/métodos , Terminología como Asunto , Técnica Delphi , Suplementos Dietéticos/clasificación , Endocrinología/organización & administración , Alimentos Formulados/clasificación , Humanos , Lenguaje , Necesidades Nutricionales , Ciencias de la Nutrición/organización & administración , Apoyo Nutricional/clasificación , Sociedades Médicas , Sociedades Científicas , España
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA